Symbio Pharmaceuticals Limited's total assets for Q4 2024 were ¥4.97B, a decrease of -18.12% from the previous quarter. JP:4582 total liabilities were ¥770.77M for the fiscal quarter, a -15.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.